Dexamethasone and phosphoramidon inhibit endothelin release by cultured nonciliated bronchiolar epithelial (Clara) cells

Johanne Laporte, Pedro D'Orléans-Juste, Gurmukh Singh, Pierre Sirois

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The release of immunoreactive endothelin (ir-ET) by cultured Clara cells isolated from guinea pig lung was investigated. Clara cells were cultured in DMEM-F12 with 10% fetal bovine serum for 4-5 days. The basal release of ir-ET, measured by radioimmunoassay, from cultured guinea pig Clara cells incubated for 2, 6, and 10 h was 59.6 ± 8.6, 206.0 ± 25.0, and 291.0 ± 16.5 pg/ml, respectively. Treatment with phosphoramidon (1 mM) for 45 min decreased the release of ir-ET by 73% and 76% in 6- and 10-h incubation periods, respectively. In addition, treatment with dexamethasone (1 μM) for 24 h significantly attenuated the release of ir-ET by 62% and 71% during 6- and 10-h incubation periods, respectively. Our results show that Clara cells isolated from guinea pig can synthesize significant amounts of ir-ET and that a phos-phoramidon-sensitive metalloprotease appears to be responsible for the generation of endothelin. This basal release of ir-ET was significantly attenuated by dexamethasone.

Original languageEnglish (US)
Pages (from-to)S53-S55
JournalJournal of Cardiovascular Pharmacology
Volume26
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Endothelins
Dexamethasone
Epithelial Cells
Guinea Pigs
Cultured Cells
Metalloproteases
phosphoramidon
Radioimmunoassay
Lung
Serum

Keywords

  • Clara cells
  • Dexamethasone
  • Endothelin
  • Phosphoramidon

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Dexamethasone and phosphoramidon inhibit endothelin release by cultured nonciliated bronchiolar epithelial (Clara) cells. / Laporte, Johanne; D'Orléans-Juste, Pedro; Singh, Gurmukh; Sirois, Pierre.

In: Journal of Cardiovascular Pharmacology, Vol. 26, 01.01.1995, p. S53-S55.

Research output: Contribution to journalArticle

@article{b3e359f9b6d345d8b3ff57723d1a8ec8,
title = "Dexamethasone and phosphoramidon inhibit endothelin release by cultured nonciliated bronchiolar epithelial (Clara) cells",
abstract = "The release of immunoreactive endothelin (ir-ET) by cultured Clara cells isolated from guinea pig lung was investigated. Clara cells were cultured in DMEM-F12 with 10{\%} fetal bovine serum for 4-5 days. The basal release of ir-ET, measured by radioimmunoassay, from cultured guinea pig Clara cells incubated for 2, 6, and 10 h was 59.6 ± 8.6, 206.0 ± 25.0, and 291.0 ± 16.5 pg/ml, respectively. Treatment with phosphoramidon (1 mM) for 45 min decreased the release of ir-ET by 73{\%} and 76{\%} in 6- and 10-h incubation periods, respectively. In addition, treatment with dexamethasone (1 μM) for 24 h significantly attenuated the release of ir-ET by 62{\%} and 71{\%} during 6- and 10-h incubation periods, respectively. Our results show that Clara cells isolated from guinea pig can synthesize significant amounts of ir-ET and that a phos-phoramidon-sensitive metalloprotease appears to be responsible for the generation of endothelin. This basal release of ir-ET was significantly attenuated by dexamethasone.",
keywords = "Clara cells, Dexamethasone, Endothelin, Phosphoramidon",
author = "Johanne Laporte and Pedro D'Orl{\'e}ans-Juste and Gurmukh Singh and Pierre Sirois",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "26",
pages = "S53--S55",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Dexamethasone and phosphoramidon inhibit endothelin release by cultured nonciliated bronchiolar epithelial (Clara) cells

AU - Laporte, Johanne

AU - D'Orléans-Juste, Pedro

AU - Singh, Gurmukh

AU - Sirois, Pierre

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The release of immunoreactive endothelin (ir-ET) by cultured Clara cells isolated from guinea pig lung was investigated. Clara cells were cultured in DMEM-F12 with 10% fetal bovine serum for 4-5 days. The basal release of ir-ET, measured by radioimmunoassay, from cultured guinea pig Clara cells incubated for 2, 6, and 10 h was 59.6 ± 8.6, 206.0 ± 25.0, and 291.0 ± 16.5 pg/ml, respectively. Treatment with phosphoramidon (1 mM) for 45 min decreased the release of ir-ET by 73% and 76% in 6- and 10-h incubation periods, respectively. In addition, treatment with dexamethasone (1 μM) for 24 h significantly attenuated the release of ir-ET by 62% and 71% during 6- and 10-h incubation periods, respectively. Our results show that Clara cells isolated from guinea pig can synthesize significant amounts of ir-ET and that a phos-phoramidon-sensitive metalloprotease appears to be responsible for the generation of endothelin. This basal release of ir-ET was significantly attenuated by dexamethasone.

AB - The release of immunoreactive endothelin (ir-ET) by cultured Clara cells isolated from guinea pig lung was investigated. Clara cells were cultured in DMEM-F12 with 10% fetal bovine serum for 4-5 days. The basal release of ir-ET, measured by radioimmunoassay, from cultured guinea pig Clara cells incubated for 2, 6, and 10 h was 59.6 ± 8.6, 206.0 ± 25.0, and 291.0 ± 16.5 pg/ml, respectively. Treatment with phosphoramidon (1 mM) for 45 min decreased the release of ir-ET by 73% and 76% in 6- and 10-h incubation periods, respectively. In addition, treatment with dexamethasone (1 μM) for 24 h significantly attenuated the release of ir-ET by 62% and 71% during 6- and 10-h incubation periods, respectively. Our results show that Clara cells isolated from guinea pig can synthesize significant amounts of ir-ET and that a phos-phoramidon-sensitive metalloprotease appears to be responsible for the generation of endothelin. This basal release of ir-ET was significantly attenuated by dexamethasone.

KW - Clara cells

KW - Dexamethasone

KW - Endothelin

KW - Phosphoramidon

UR - http://www.scopus.com/inward/record.url?scp=0028792022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028792022&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - S53-S55

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

ER -